Preprint · CC-BY
via OpenAlex
Prevalence of Hypertension and Type 2 Diabetes Mellitus among Patients with Metabolic Syndrome in Rural Southern Nigeria: Gender and Age Disparities
Harmony Uchenna Ibezim, Helen Kwipnchep Njoya, Hendrith Esene, Shalom Enahoro Azenabor, Sule, Saeed
PubMed · 2024 · ▲ 2 citations
Abstract
Background: Metabolic syndrome (MetS) is a cluster of interconnected risk factors, including obesity, hypertension, elevated blood sugar, and abnormal lipid profiles. Its increasing prevalence globally poses a significant public health concern. This study investigated the prevalence of hypertension and type 2 diabetes mellitus (T2DM) in patients with MetS, considering age and gender in a rural teaching hospital. Methodology: Conducted at Igbinedion University Teaching Hospital, Edo State, the study involved 75 patients selected through simple random sampling using the 2009 Joint Interim Statement (JIS) criteria of the IDF/AHA/NHLBI. It utilised an observational, cross-sectional, and retrospective design, focusing on individuals aged 18 years and older who consented to participate. Data was analysed using IBM SPSS version 23, with p < 0.05 considered significant. Results: The findings indicated that 60% of patients with MetS had hypertension, 17.3% had T2DM, and 22.7% were diagnosed with both conditions. Among hypertensive patients, 57.3% were female (P = 0.110). For T2DM, 25.3% of patients were female (P = 0.766). The prevalence of both T2DM (P = 0.106) and hypertension (P = 0.708) was higher in middle-aged patients compared to other age groups. Conclusion: This study highlights the significant prevalence of hypertension and T2DM among patients with MetS in a rural teaching hospital, with notable variations across gender and age groups. While hypertension was more common in females, T2DM showed no significant gender disparity. Middle-aged individuals exhibited a higher prevalence of both conditions, underscoring the need for targeted screening and intervention strategies in this demographic.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.71480/nmj.v66i1.706
- Canonical
- link ↗
- Fetched
- 2026-10-20 MST
Cite this
APA
Ibezim, H.U., Njoya, H.K., Esene, H., Azenabor, S.E., & Saeed, S. (2024). Prevalence of Hypertension and Type 2 Diabetes Mellitus among Patients with Metabolic Syndrome in Rural Southern Nigeria: Gender and Age Disparities. <em>PubMed</em>. https://doi.org/10.71480/nmj.v66i1.706
Vancouver
Ibezim HU, Njoya HK, Esene H, Azenabor SE, Saeed S. Prevalence of Hypertension and Type 2 Diabetes Mellitus among Patients with Metabolic Syndrome in Rural Southern Nigeria: Gender and Age Disparities. PubMed. 2024. doi:10.71480/nmj.v66i1.706.
BibTeX
@unpublished{harmony2024Preval,
title = {Prevalence of Hypertension and Type 2 Diabetes Mellitus among Patients with Metabolic Syndrome in Rural Southern Nigeria: Gender and Age Disparities},
author = {Harmony Uchenna Ibezim and Helen Kwipnchep Njoya and Hendrith Esene and Shalom Enahoro Azenabor and Sule, Saeed},
journal = {PubMed},
year = {2024},
doi = {10.71480/nmj.v66i1.706},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
International Journal of Vascular Medicine 2025
Open access · CC-BY
Age and Gender Difference in the Association of Metabolic Syndrome and Peripheral Artery Disease Among Patients With Type 2 Diabetes Mellitus
Frontiers in aging 2026
Open access · OA
Glycemic dysregulation and cognitive impairment in aging adults: a cross-sectional study with amyloid biomarker correlation.
GeroScience 2026
Open access · CC-BY
Expected lifespan and healthspan among rural and urban individuals in Java, Indonesia
International Journal of Advances in Medicine 2016
Open access · OA
The study of prevalence of hyperuricemia and metabolic syndrome in type 2 diabetes mellitus
Metabolic Syndrome and Related Disorders 2007
Citation only
Metabolic Syndrome in Type 2 Diabetes Mellitus in Isfahan, Iran: Prevalence and Risk Factors
Diabetes & Metabolic Syndrome Clinical Research & Reviews 2017
Citation only